Investors
Investor Documents
-
Half-Year Report on the Liquidity Contract - December 31, 2015
January 8, 2016 -
2016 Financial Agenda
December 10, 2015 -
2015 Half-Year Results - €57.7 million raised on Euronext and Significant clinical progress on chronic Hepatitis B and HIV/AIDS
September 29, 2015 -
2015 Half-Year Financial Report
September 29, 2015 -
International Offering Memorandum
June 4, 2015 -
ABIVAX Announces the Registration of its Reference Document by AMF
May 19, 2015 -
ABIVAX Launches IPO on the Regulated Market of Euronext in Paris
June 9, 2015 -
Great success of ABIVAX IPO on Euronext Paris, with €57.7 million raised
June 23, 2015